Filed: 11/14/2024ACC: 0001964437-24-000011
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $279.77M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$279.77M
Total AUM (reported)
12.36M
Total Shares
Allocation by class
COM$183.01M65.4%
SPONSORED ADR$41.89M15.0%
COM NEW$17.49M6.3%
CLASS A ORD$15.07M5.4%
ADS$8.75M3.1%
SPONSORED ADS$7.47M2.7%
COM CL A$4.62M1.6%
Portfolio Concentration
Top 3$78.44M28.0%
4–10$119.11M42.6%
11–25$82.23M29.4%
Top 3 weight
28.0%
Top 10 weight
70.6%
Voting Authority Distribution
Total shares with voting rights: 12.36M
Sole
Full voting authority
12.36M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
ASCENDIS PHARMA A/S
SOLEShares200.28K
TypeSH
Market value$29.90M
10.69%
Sole
200.28K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares511.04K
TypeSH
Market value$25.11M
8.98%
Sole
511.04K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares204.99K
TypeSH
Market value$23.42M
8.37%
Sole
204.99K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares520.12K
TypeSH
Market value$19.62M
7.01%
Sole
520.12K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.71M
TypeSH
Market value$18.50M
6.61%
Sole
1.71M
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$18.50M
6.61%
Sole
1M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares331.28K
TypeSH
Market value$17.49M
6.25%
Sole
331.28K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares874.59K
TypeSH
Market value$15.81M
5.65%
Sole
874.59K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares298.97K
TypeSH
Market value$15.07M
5.39%
Sole
298.97K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares946.34K
TypeSH
Market value$14.11M
5.04%
Sole
946.34K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares22.11K
TypeSH
Market value$11.99M
4.28%
Sole
22.11K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares501.98K
TypeSH
Market value$9.66M
3.45%
Sole
501.98K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares481.13K
TypeSH
Market value$8.75M
3.13%
Sole
481.13K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares648.02K
TypeSH
Market value$7.47M
2.67%
Sole
648.02K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.37M
TypeSH
Market value$7.16M
2.56%
Sole
1.37M
Shared
0.00
None
0.00
MERUS N V
SOLEShares131.24K
TypeSH
Market value$6.56M
2.34%
Sole
131.24K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares556.49K
TypeSH
Market value$6.44M
2.30%
Sole
556.49K
Shared
0.00
None
0.00
NEUMORA THERAPEUTICS INC.
SOLEShares433K
TypeSH
Market value$5.72M
2.04%
Sole
433K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares109.57K
TypeSH
Market value$5.60M
2.00%
Sole
109.57K
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares1.12M
TypeSH
Market value$4.62M
1.65%
Sole
1.12M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares37.43K
TypeSH
Market value$2.63M
0.94%
Sole
37.43K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares195.70K
TypeSH
Market value$2.00M
0.71%
Sole
195.70K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares77.30K
TypeSH
Market value$1.48M
0.53%
Sole
77.30K
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares47.27K
TypeSH
Market value$1.11M
0.40%
Sole
47.27K
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
SOLEShares31.53K
TypeSH
Market value$1.05M
0.38%
Sole
31.53K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 200.28K | SH | $29.90M 10.69% | 200.28K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 511.04K | SH | $25.11M 8.98% | 511.04K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 204.99K | SH | $23.42M 8.37% | 204.99K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 520.12K | SH | $19.62M 7.01% | 520.12K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.71M | SH | $18.50M 6.61% | 1.71M | 0.00 | 0.00 |
CARGO THERAPEUTICS INCSOLE | COM | 1M | SH | $18.50M 6.61% | 1M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 331.28K | SH | $17.49M 6.25% | 331.28K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 874.59K | SH | $15.81M 5.65% | 874.59K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 298.97K | SH | $15.07M 5.39% | 298.97K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 946.34K | SH | $14.11M 5.04% | 946.34K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 22.11K | SH | $11.99M 4.28% | 22.11K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 501.98K | SH | $9.66M 3.45% | 501.98K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 481.13K | SH | $8.75M 3.13% | 481.13K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 648.02K | SH | $7.47M 2.67% | 648.02K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.37M | SH | $7.16M 2.56% | 1.37M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 131.24K | SH | $6.56M 2.34% | 131.24K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 556.49K | SH | $6.44M 2.30% | 556.49K | 0.00 | 0.00 |
NEUMORA THERAPEUTICS INC.SOLE | COM | 433K | SH | $5.72M 2.04% | 433K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 109.57K | SH | $5.60M 2.00% | 109.57K | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 1.12M | SH | $4.62M 1.65% | 1.12M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 37.43K | SH | $2.63M 0.94% | 37.43K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | COM | 195.70K | SH | $2.00M 0.71% | 195.70K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 77.30K | SH | $1.48M 0.53% | 77.30K | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 47.27K | SH | $1.11M 0.40% | 47.27K | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INSOLE | COM | 31.53K | SH | $1.05M 0.38% | 31.53K | 0.00 | 0.00 |